Dr. Sinicrope on Mismatch Repair-Deficient Patients With Metastatic Colorectal Cancer

Mismatch Repair (MMR) Deficiency in Colorectal Cancer

What is microsatellite instability or MSI?

Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient LARC

Dr. Cercek on Induction Chemotherapy in Mismatch Repair Deficient Rectal Cancer

What Do We Need to Know About New Therapeutics for Patients With Endometrial Cancer?

MMR by IHC vs MSI by PCR

Dr. Jennifer Wu on Immunotherapy in Mismatch Repair Deficient CRC

Mismatch repair protein loss in breast cancer

Tumor Characteristics Provide Evidence for Mismatch Repair Variant Pathogenicity | Science In 60

Dr. Goldberg on PD-1 Blockade in Tumors with Mismatch Repair Deficiency

Mismatch Repair Animation

Effects of Mismatch Repair Deficiency and Microsatellite Instability on Gastric Cancer Outcomes

Mismatch repair deficiency may play a role in the development of colorectal cancer

Hereditary colorectal cancer and gastric cancer

Advancing Treatment Options for Mismatch Repair-Deficient Metastatic Colorectal Cancers

Alan Venook, MD, discusses uniqueness of MSI-High/mismatch repair deficient CRC patients

9/9/16: Colorectal Cancer: The Role of Inflammation and DNA Mismatch Repair for Patient Outcome

Colorectal Cancer: MSI Testing to All Patients and How to Test

A 3D animation of mismatch repair in E. coli